ClinicalTrials.gov
public full text
Public Domain
Novel ECCO2R Device for Hypercapnic Respiratory Failure
The objective of this study is to assess the efficacy and safety of this new Prismalung+ membrane in its intended clinical setting by demonstrating a reduction in ventilatory parameters and pulmonary energy load or the successful maintenance of spontaneous breathing, respectively, the absence of the need to initiate vv-ECMO therapy, and initial survival.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- ECCO2R in the Treatment of Acute Exacerbation of COPD With Severe Hypercapnia#855807
- Evaluation of Vital Capacity#1163684
- Treatment of Nasal Airway Obstruction Using the Aerin Medical Device#1172153
- Electrical Impedence Tomography With ENLIGHT2100#833139
- Clinical Validation of a Novel, Accelerometer Based, Continuous Respiratory Rate Sensor#863848
Record · ID 1112648
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive